Breast cancer patients – beware! Common breast cancer drug tamoxifen may quadruple your risk of developing a more aggressive cancer in your healthy breast. FOUR times the risk!
A new study (published in Cancer Research) found that tamoxifen therapy brings on a 4.4-fold increased risk of a specific, particularly aggressive form of breast cancer (called estrogen receptor negative contralateral breast cancer)…along with all of its other risks. Risks that include blood clots, stroke, and uterine cancer, just to name a few. On top of those potential risks, about 40% women who do suffer through tamoxifen treatment suffer a cancer recurrence.
Of course, the researchers say this new finding – the four-fold risk of aggressive cancer – is no reason to stop taking tamoxifen, claiming that the benefits outweigh the risks.
Please talk with your doctor about other treatment options. Because chancing a 440% increased risk of more aggressive cancer from a treatment that’s only 60% effective – well, those sound like very bad odds.